Verily: Amy Abernethy
Verily has appointed Amy Abernethy as president of its clinical research business. Abernethy was most recently principal deputy commissioner of food and drugs and acting chief information officer at the US Food and Drug Administration. Prior to her role at FDA, Abernethy was chief medical officer, chief scientific officer, and senior vice president of Flatiron Health, now part of Roche. Abernethy has also been a professor of medicine at Duke University School of Medicine; director of the Center for Learning Health Care in the Duke Clinical Research Institute; and director of the Duke Cancer Care Research Program in the Duke Cancer Institute.